Aimeike (300896.SZ) obtained a drug registration certificate for exclusive distribution of injectable botulinum toxin products

Zhitongcaijing · 3d ago

Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's exclusive distribution of injectable type A botulinum toxin products produced by South Korea's Huons BP in China has obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration.